What is NDC 52652-3001?

52652-3001 is the product NDC for Qbrelis (lisinopril), Lisinopril 1 mg/mL solution, listed with the FDA by Azurity Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Azurity Pharmaceuticals, Inc., NDC labeler code 52652. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Qbrelis?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Qbrelis NDC 52652-3001 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)52652-3001Labeler and product segments. Claims need a package NDC.

Product NDC at billing width52652-3001Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
52652-3001-1	52652300101	150 mL in 1 BOTTLE (52652-3001-1)Marketed from Aug 29, 2016

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Qbrelis
Generic name (nonproprietary): lisinopril
Active ingredients: Lisinopril — 1 mg/mL
Dosage form: Solution
Route: Oral
Labeler: Azurity Pharmaceuticals, Inc.NDC labeler code 52652
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 208401
Marketing start: Aug 29, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)
Identifiers: Product ID 52652-3001_461e97d5-c8b3-75a7-e063-6394a90a6ec6SPL ID 461e97d5-c8b3-75a7-e063-6394a90a6ec6SPL set ID 9f6e4e57-a489-4b36-b093-b93865d3717cRxCUI 1806884, 1806890UNII E7199S1YWR
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N452652300101 followed by a unit qualifier and the quantity

Package 52652-3001-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 16, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

QBRELIS is an angiotensin converting enzyme (ACE) inhibitor indicated for: Treatment of hypertension in adults and pediatric patients 6 years of age and older ( 1.1 ). Adjunct therapy for heart failure ( 1.2 ). Treatment of Acute Myocardial Infarction ( 1.3 ). 1.1 Hypertension QBRELIS is indicated for the treatment of hypertension in adult patients and pediatric patients 6 years of age and older to lower blood pressure. Lowering blood pressure lowers the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes. Control of high blood …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 52652-3001

What is NDC 52652-3001?: 52652-3001 is the product NDC for Qbrelis (lisinopril), Lisinopril 1 mg/mL solution, listed with the FDA by Azurity Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Qbrelis (Lisinopril).
What is the active ingredient?: Lisinopril.
Who is the labeler?: Azurity Pharmaceuticals, Inc., NDC labeler code 52652. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Qbrelis?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Qbrelis (Lisinopril) NDC 52652-3001